Lpl Financial LLC Evolus, Inc. Transaction History

Lpl Financial LLC

$246 Billion
Q1 2025

A detailed history of Lpl Financial LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 22,594 shares of EOLS stock, worth $271,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,594

Previous 21,071 7.23%

Holding current value

$271,353

Previous $232,000 16.81%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$9.47 - $15.04 $14,422 - $22,905	1,523 Added 7.23%	22,594 $271,000
Q3 2024 Nov 08, 2024	SELL	$10.66 - $17.48 $7,451 - $12,218	-699 Reduced 3.21%	21,071 $341,000
Q2 2024 Aug 07, 2024	SELL	$10.45 - $13.76 $36,167 - $47,623	-3,461 Reduced 13.72%	21,770 $236,000
Q1 2024 May 10, 2024	SELL	$9.99 - $14.91 $23,426 - $34,963	-2,345 Reduced 8.5%	25,231 $353,000
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $40,249 - $55,766	-5,296 Reduced 16.11%	27,576 $290,000
Q3 2023 Nov 13, 2023	BUY	$7.15 - $10.2 $657 - $938	92 Added 0.28%	32,872 $300,000
Q2 2023 Jul 31, 2023	BUY	$7.23 - $10.52 $18,696 - $27,204	2,586 Added 8.56%	32,780 $238,000
Q1 2023 May 10, 2023	SELL	$7.81 - $11.05 $3,248 - $4,596	-416 Reduced 1.36%	30,194 $255,000
Q4 2022 Feb 07, 2023	SELL	$6.52 - $8.95 $22,317 - $30,635	-3,423 Reduced 10.06%	30,610 $229,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $36,503 - $64,538	4,704 Added 16.04%	34,033 $274,000
Q1 2022 May 16, 2022	SELL	$5.22 - $11.78 $1,555 - $3,510	-298 Reduced 1.01%	29,329 $329,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $34,491 - $53,824	-6,423 Reduced 17.82%	29,627 $193,000
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $30,323 - $56,320	-4,120 Reduced 10.26%	36,050 $275,000
Q2 2021 Aug 13, 2021	BUY	$8.42 - $13.96 $4,167 - $6,910	495 Added 1.25%	40,170 $508,000
Q1 2021 May 14, 2021	SELL	$3.2 - $16.51 $1,193 - $6,158	-373 Reduced 0.93%	39,675 $515,000
Q4 2020 Feb 12, 2021	SELL	$2.92 - $4.84 $190,573 - $315,882	-65,265 Reduced 61.97%	40,048 $135,000
Q3 2020 Nov 09, 2020	SELL	$3.03 - $5.48 $98,068 - $177,365	-32,366 Reduced 23.51%	105,313 $412,000
Q2 2020 Aug 13, 2020	BUY	$3.53 - $6.17 $407,937 - $713,023	115,563 Added 522.53%	137,679 $730,000
Q1 2020 May 14, 2020	SELL	$3.53 - $12.21 $2,576 - $8,913	-730 Reduced 3.2%	22,116 $92,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $9,252 - $13,878	-799 Reduced 3.38%	22,846 $278,000
Q3 2019 Nov 13, 2019	SELL	$13.91 - $19.87 $33,662 - $48,085	-2,420 Reduced 9.28%	23,645 $369,000
Q2 2019 Aug 09, 2019	BUY	$13.19 - $28.36 $74,325 - $159,808	5,635 Added 27.58%	26,065 $381,000
Q1 2019 May 08, 2019	BUY	$12.43 - $28.91 $253,944 - $590,631	20,430 New	20,430 $461,000

Others Institutions Holding EOLS

# of Institutions

178

Shares Held

50.4M

Call Options Held

42.2K

Put Options Held

2.5K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $674M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Evolus, Inc. Transaction History